Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
BMS unveils first look at late-stage Alzheimer's psychosis data
Bristol Myers Squibb is offering an early peek at its phase 3 Alzheimer's psychosis program that bodes well for the data drops ahead.
Fraiser Kansteiner
Nov 18, 2026 3:51pm
Beren's FDA nod in NPC was a long time coming
Nov 18, 2026 11:37am
Digital Twins: Advancing Clinical Evidence Strategy
Brought to you by
IQVIA
FDA moves to rescind Salerno's liquid cholesterol drug nod
Nov 18, 2026 9:54am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Overton’s FDA nomination pulled by White House
Nov 17, 2026 9:15pm